Islet Cell Carcinoma

This is a type of cancer that starts in the small clusters of cells within the pancreas called islet cells. These cells are important for making hormones like insulin. This cancer usually affects the non-insulin-producing cells.

Condition

What people with Islet Cell Carcinoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Octreotide for Islet Cell Carcinoma?

NameHow it went

About Islet Cell Carcinoma

What It Is

Islet cell carcinoma is a cancer that starts in the islet cells of the pancreas, the small clusters of cells that make hormones such as insulin and glucagon. Doctors today usually call it a pancreatic neuroendocrine tumor (pancreatic NET). Not every islet cell tumor is cancer: the term islet cell carcinoma refers to the ones that can invade nearby tissue or spread, most often to the liver. It is different from the far more common pancreatic cancer, adenocarcinoma, which grows from the cells that make digestive juices. The two have different causes, treatments and outlooks, so the general statistics people find for pancreatic cancer do not apply here. Islet cell tumors make up only about 1 to 2 percent of pancreatic tumors, and many grow slowly. About 90 percent are nonfunctional, meaning they do not release extra hormone. These can grow for years without symptoms and are often found on a scan done for another reason, or once they cause weight loss, belly or back pain, or yellowing of the skin and eyes. The rest are functional: the tumor overproduces one hormone, and that hormone causes the symptoms. A gastrinoma drives excess stomach acid, ulcers and diarrhea; an insulinoma causes episodes of low blood sugar (most insulinomas are not cancer); a glucagonoma raises blood sugar and can cause a spreading, blistering rash; and the rarer VIPoma causes severe watery diarrhea.

Causes & Risk Factors

In most people the cause is unknown. The tumor begins when changes in islet cells make them grow and divide abnormally, and usually nothing a person did can be identified as the reason. A family history of these tumors or of cancer, type 2 diabetes, smoking and long-term inflammation of the pancreas (chronic pancreatitis) are linked to higher risk. Smoking is the one of these a person can change, but none of them means a tumor was inevitable or explains an individual case. Some inherited syndromes raise the risk considerably, most notably multiple endocrine neoplasia type 1 (MEN1), along with von Hippel-Lindau syndrome, neurofibromatosis type 1 and tuberous sclerosis. Most people with islet cell carcinoma do not have one of these. Genetic counseling is often suggested for people diagnosed young, with several tumors at once, with a functional tumor, with spread at diagnosis or with a relevant family history, because a positive result can change treatment and lead to testing for relatives.

How It's Diagnosed

Diagnosis starts with symptoms, history and examination, then combines blood tests, imaging and a tissue sample. Blood tests measure blood sugar and specific hormones such as gastrin, insulin or glucagon when a functional tumor is suspected, and sometimes chromogranin A, a protein that can be raised in neuroendocrine tumors. A raised level supports the diagnosis but does not prove it on its own. A CT (computed tomography) scan with contrast dye or an MRI (magnetic resonance imaging) scan shows the tumor, its size and whether it has reached blood vessels, lymph nodes or the liver. Endoscopic ultrasound, a thin camera passed through the mouth with an ultrasound probe on its tip, can find small tumors and take a needle sample. Many of these tumors carry somatostatin receptors, so a scan using a mildly radioactive tracer that sticks to those receptors (a DOTATATE PET scan, often combined with CT) can light them up anywhere in the body; this helps with staging and shows whether receptor-targeted treatments are likely to work. The biopsy confirms the diagnosis and sets the grade. Grade 1 cells look close to normal and divide slowly, while grade 3 cells look abnormal and divide quickly; a lower grade generally means a better outlook. Stage (I to IV) describes how far the tumor has spread. Together, grade and stage guide most treatment decisions.

Treatment Options

When the tumor can be completely removed, surgery is the main treatment and offers the best chance of cure. The operation depends on where the tumor sits: removing just the tumor, removing the body and tail of the pancreas (sometimes with the spleen), or a Whipple procedure for tumors in the head of the pancreas, a major operation that also removes part of the small intestine, bile duct and stomach. Spread to the liver can sometimes be removed surgically too. Very small, slow-growing tumors that cause no symptoms may instead be watched with regular scans. When surgery cannot remove everything, treatment aims to control growth and symptoms, often for years. Somatostatin analogs (octreotide or lanreotide, given as injections) calm hormone-related symptoms and can slow growth in tumors that carry somatostatin receptors. Peptide receptor radionuclide therapy (PRRT) uses the same receptor to deliver radiation directly into tumor cells; lutetium Lu 177 dotatate (Lutathera) is given as a series of infusions. Targeted medicines such as everolimus and sunitinib, taken by mouth, block signals the tumor uses to grow, and chemotherapy, commonly capecitabine with temozolomide, is used for faster-growing or more advanced disease. Each brings its own side effects, and the order is chosen by grade, extent and receptor status. Tumors in the liver can also be treated directly by burning or freezing them (ablation) or by blocking their blood supply (embolization). For functional tumors, controlling the hormone comes first: acid-reducing medicines for gastrinoma, frequent meals and medicines to keep blood sugar up for insulinoma, and fluids and electrolytes for VIPoma. Because these cancers are rare, care at a center experienced with neuroendocrine tumors and discussion of clinical trials can be valuable.

What to Expect

The course varies more than with most cancers. Many islet cell carcinomas grow slowly, and people can live for many years, even with spread to the liver, on a cycle of treatment, monitoring and treatment changes. Higher-grade tumors behave more aggressively. In US cancer registry data from 2015 to 2021, about 91 percent of people whose tumor was confined to the pancreas were alive five years after diagnosis, compared with about 64 percent when it had reached nearby lymph nodes or tissue and 19 percent when it had spread to distant organs. These are group averages that predate some newer treatments and cannot predict one person's outcome. Even after complete removal, these tumors can come back, sometimes years later, so follow-up with scans and blood tests usually continues for a long time. Those results guide whether to continue, change or pause treatment. Life after pancreatic surgery may involve digestive changes or diabetes if much of the pancreas was removed, and longer-term treatment often means regular injections or infusions and managing side effects. Living with a rare, often slow cancer brings its own strain: long stretches of monitoring, uncertainty and frequent appointments. Palliative care, which focuses on symptoms and quality of life, can be part of care at any stage alongside cancer treatment, and support groups for neuroendocrine tumors can help people and families feel less isolated.

When to Seek Help

Arrange a visit if you have unexplained weight loss, ongoing belly or back pain, recurring ulcers or heartburn that do not settle with usual treatment, or repeated spells of sweating, shakiness, hunger or confusion that ease after eating. If you have MEN1 or another linked syndrome, keep to the screening plan your specialists set. If you already have a diagnosis, contact your care team the same day for severe watery diarrhea with dizziness or very little urine, yellowing of the skin or eyes, or pain, swelling and warmth in one leg or arm, which can signal a blood clot. For someone with an insulin-making tumor, call 911 if they have a seizure, pass out or are too confused to eat or drink safely, since this can mean dangerously low blood sugar. Sudden shortness of breath or chest pain, especially with a glucagonoma, can mean a clot in the lung and needs emergency care.

Questions to Ask Your Doctor

  1. 1.Is my tumor functional or nonfunctional, and what are its grade and stage?
  2. 2.Can the tumor be removed completely, and what would the operation mean for my digestion and blood sugar afterward?
  3. 3.Does my tumor show somatostatin receptors on scans, and what does that mean for my treatment options?
  4. 4.Should I have genetic counseling, and should my relatives be tested?
  5. 5.How often will I need scans and blood tests, and what changes would lead us to change treatment?

Last reviewed • Oct 2026

Educational content, not medical advice.